SCHEMBL21889082

SCHEMBL21889082

CCn1c2ccccc2c2ccc(-c3cccc(-c4ccccc4)n3)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.51
NPY5R Q15761 6/20 0.50
PTGES O14684 1/20 0.47
METAP2 P50579 1/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HPGD P15428 2/20 0.46
MAPT P10636 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
HBB P68871 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RAC2 P15153 1/20 0.45
RAC3 P60763 1/20 0.45
CDC42 P60953 1/20 0.45
RAC1 P63000 1/20 0.45
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889085 0.96 METAP2 (0.49) KDM1ANPY5RPTGESMETAP2MEN1
SCHEMBL21888858 0.91 NPY5R (0.50) KDM1ANPY5RPTGESMETAP2ALDH1A1
SCHEMBL13620583 0.84 KDM4E (0.54) KDM1ANPY5RMETAP2ALDH1A1KDM4E
SCHEMBL13620587 0.84 KDM4E (0.54) KDM1ANPY5RMETAP2ALDH1A1KDM4E
SCHEMBL16865779 0.82 KDM1A (0.50) KDM1ANPY5RPTGESMETAP2ALDH1A1
SCHEMBL5999686 0.82 KDM4E (0.59) KDM1ANPY5RALDH1A1KDM4EMEN1
SCHEMBL14114045 0.81 NPY5R (0.57) KDM1ANPY5RPTGESALDH1A1KDM4E
SCHEMBL16639587 0.81 PTGES (0.53) KDM1ANPY5RPTGESALDH1A1KDM4E
SCHEMBL14805227 0.81 NPY5R (0.59) NPY5RPTGESALDH1A1KDM4EMEN1
SCHEMBL15590654 0.80 KDM1A (0.54) KDM1ANPY5RPTGESALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584739-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-02-21 US disclosed
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CLTB, CYBA KDM1A 4562/4885NPY5R 4065/4885PTGES 1607/4885
US-11584739-B2 Composition of matter for use in organic light-emitting diodes CRY2, CLTB, CYBA KDM1A 4562/4885NPY5R 4065/4885PTGES 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.